Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018 <i>(Commentary, p. 3026)</i>
Chintamani D. Atreya(Center for Biologics Evaluation and Research), Paul M. Ness(Johns Hopkins University), Stephen J. Wagner(American Red Cross), Andrew Cap(United States Army Institute of Surgical Research), Richard J. Benjamin(Cerus (United States)), James P. AuBuchon(Dartmouth–Hitchcock Medical Center), David Reeve(American Red Cross), Brian Custer(University of California, San Francisco), Anna Razatos(Terumo (United States)), Willy A. Flegel(National Institutes of Health Clinical Center), Monique P. Gelderman(Center for Biologics Evaluation and Research), Claudia S. Cohn(University of Minnesota), Raymond P. Goodrich(Colorado State University), Michael P. Busch(Vitalant), Sara Rutter(Yale University), José A. Cancelas(Harvard University), Simone A. Glynn(National Institutes of Health), Steve Kleinman(University of British Columbia), Michelle Maclean(University of Strathclyde), Edward L. Snyder(Yale University), Dana V. Devine(University of British Columbia)
Cited by 35
Related Papers
Clinical Practice Guidelines From the AABB
|JAMA|2016|1.1k
Patient Blood Management
|JAMA|2019|619
Global Epidemiology of Hepatitis B Virus
|Journal of Clinical Gastroenterology|2004|601